We will further look into this and explore how we can help patients with addiction, potentially with GLP-1, Lange said, also adding that it has to be addressed in a scientific, and obviously also from a regulatory perspective, very rigorous way so we can really see the potential impact of GLP-1 in that space. However, in response to questions from Biospace, a Novo spokesperson said that Lange was referring to the already ongoing work studying semaglutide on liver damage and alcohol use in its phase 2 trial, and that the company has no plans to study the drug in broader addiction indications
ERFFI1 (ErbB receptor feedback inhibitor 1) is constitutively expressed and there is excess mitogenic signaling
CJC-1295 was never on the 503A list to begin with , it has always existed in a regulatory gray zone, available primarily through research-chemical channels or specific compounding arrangements
Some common side effects that semaglutide can have on your digestive system include: Nausea Vomiting Diarrhea Constipation Stomach upset Very little appetite Some antibiotics also cause side effects, like nausea, diarrhea, or an upset stomach, so if you are using two medications that are both causing side effects, you might feel worse than you would if just using one of them alone